A
The startup develops a targeted therapy for Upper Respiratory Tract Inflammation Disease (URTD) in cats, specifically addressing feline rhinitis caused by feline herpesvirus (FHV-1) and feline calicivirus (FCV). This treatment offers pet owners an effective solution for managing and preventing the symptoms associated with cat flu.
PolskaFounded 2020
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a targeted therapy for Upper Respiratory Tract Inflammation Disease (URTD) in cats, specifically addressing feline rhinitis caused by feline herpesvirus (FHV-1) and feline calicivirus (FCV). This treatment offers pet owners an effective solution for managing and preventing the symptoms associated with cat flu.